Print This Article (X)  | Close this Window (X)
Media Contact: Vincent Joseph Dollard
  vdollar@emory.edu
  (404) 727-3366
25 September 2007
Emory Winship Cancer Institute Appoints Two New Faculty
Brian Leyland-Jones, MD, director of the Emory Winship Cancer Institute, and Fadlo Khuri, MD, section head of hematology and oncology at Emory Winship, have announced the appointment of two new faculty members.

R. Donald Harvey, PharmD, has joined the faculty of Emory Winship as assistant professor of hematology and oncology and director of the Phase I clinical trials section. Morgan McLemore, MD, has joined Emory Winship as assistant professor of hematology and oncology with a secondary appointment in medicine.

"We are delighted to welcome both Drs. Harvey and McLemore to Emory Winship," says Dr. Leyland-Jones. "They bring a wealth of clinical and research experience to our growing cancer program and to our patients. Recruiting exceptional faculty like Drs. Harvey and McLemore is a top priority for Emory Winship as we continue to work toward National Cancer Institute Comprehensive Cancer Institute designation."

Before joining Emory Winship, Dr. Harvey was medical science liaison for Alexion Pharmaceuticals, Inc. Prior to that appointment, he served as clinical specialist in hematology and oncology and director of the hematology and oncology residency program at the Georgia Cancer Center of Excellence at Grady Health System.

Dr. Harvey received his doctoral degree from the University of North Carolina and completed his residency at the University of Kentucky Medical Center and College of Pharmacy. He is board certified as a pharmacotherapy specialist and as an oncology pharmacist. Widely published in peer-reviewed journals, Dr. Harvey's research interests include pharmacokinetics, pharmacodynamics and pharmacogenetics.

Dr. McLemore joins Emory Winship from the University of Texas Health Science Center at San Antonio where he served as assistant professor in the department of medicine's division of hematology.

Dr. McLemore received his medical degree from the University of Texas Health Science Center at San Antonio. He completed his residency in internal medicine and fellowship training in hematology and oncology at Washington University in St. Louis. He is board certified in medical oncology, hematology and internal medicine, and is a member of the American Society of Hematology.

Dr. McLemore has an active research laboratory focusing on myeloid differentiation, and his clinical interests are in both benign and malignant hematologic disorders, with a special focus on marrow failure syndromes and clonal myeloid disorders. Dr. McLemore received his medical degree from the University of Texas Health Science Center at San Antonio. He did his residency in internal medicine and fellowship training in hematology and oncology at Washington University in St. Louis. He is board certified in medical oncology, hematology and internal medicine and is a member of the American Society of Hematology.

Dr. McLemore has an active research laboratory focusing on myeloid differentiation, and his clinical interests are in both benign and malignant hematologic disorders, with a special focus on marrow failure syndromes and clonal myeloid disorders.

© Emory University 2018

<<::Back to Press Releases